News for diabetes care! The #FDA has approved #Merilog, the 1st rapid-acting insulin biosimilar & 3rd biosimilar insulin product approved in the U.S. 💉
Biosimilars like Merilog can help make insulin more accessible & affordable for the millions who rely on it.
Read more: www.fda.gov/news-events/...

Merilog SoloStar insulin pen (insulin aspart-szjj) with a labeled dosage of 100 units/mL (U-100). The pen is a 3 mL prefilled injection device for single-patient use. The label indicates it is available by prescription only. Courtesy of FDA and Sanofi. Graphic design by Zebulon Rogerson.

The FDA has approved Merilog, the first rapid-acting insulin biosimilar to NovoLog, enhancing diabetes treatment options and affordability.

jcst2d.com/index.php?vi...

#FDAApproval #Merilog #InsulinBiosimilar #DiabetesCare #NovoLog

The U.S. Food and Drug Administration (FDA) has approved Merilog, the first rapid-acting insulin biosimilar to Novolog (insulin aspart), providing a new option for diabetes management.

#DiabetesCare #FDAApproval #Merilog #InsulinBiosimilar #HealthTech #MedicalInnovation

FDA Approves First Rapid-Acting Biosimilar Insulin for Diabetes Treatment The FDA has approved Merilog, the first biosimilar rapid-acting insulin aimed at improving blood sugar control for diabetes patients.

FDA Approves First Rapid-Acting Biosimilar Insulin for Diabetes Treatment #United_States #FDA #Silver_Spring #Insulin #Merilog

FDA Approves Merilog: A Landmark Biosimilar Insulin for Diabetes Management The FDA has approved Merilog, the first rapid-acting insulin biosimilar, aimed at enhancing diabetes care for patients across the U.S.

FDA Approves Merilog: A Landmark Biosimilar Insulin for Diabetes Management #United_States #FDA #Silver_Spring #diabetes #Merilog